BIOSIG TECHNOLOGIES, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)

Item 8.01             Entry Into a Material Definitive Agreement.

On November 21, 2019, BioSig Technologies, Inc. (the "Company") issued a press release announcing that the Company commenced its first clinical trial for its PURE EP™ System. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.

Item 9.01       Financial Statements and Exhibits.



(d) Exhibits



Exhibit Number   Description
99.1               Press Release, dated November 21, 2019

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses